⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1173582 | 0.84 | APP (0.40) | — | |
| SCHEMBL533162 | 0.79 | — | — | |
| SCHEMBL1173896 | 0.79 | MAPT (0.40) | — | |
| SCHEMBL1172937 | 0.79 | ACACB (0.32) | — | |
| SCHEMBL533380 | 0.76 | LTA4H (0.39) | — | |
| SCHEMBL1973187 | 0.76 | — | — | |
| SCHEMBL17501781 | 0.75 | MAOB (0.39) | — | |
| SCHEMBL17316697 | 0.75 | CHRNB2 (0.35) | — | |
| SCHEMBL224599 | 0.75 | P4HTM (0.50) | — | |
| SCHEMBL4156315 | 0.75 | CYP2D6 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3180330-B1 | 2,2,2-TRIFLUOROETHYL-THIADIAZINES | HOFFMANN LA ROCHE (CH) | 2021-03-03 | — | — | EP | claimed |
| US-9896438-B2 | 2,2,2-trifluoroethyl-thiadiazines | HOFFMANN-LA ROCHE INC. (US) | 2018-02-20 | — | — | US | claimed |
| US-20170226091-A1 | 2,2,2-TRIFLUOROETHYL-THIADIAZINES | HOFFMANN-LA ROCHE INC. | 2017-08-10 | — | — | US | claimed |
| EP-3180330-A1 | 2,2,2-TRIFLUOROETHYL-THIADIAZINES | F. Hoffmann-La Roche AG (CH) | 2017-06-21 | — | — | EP | claimed |
| US-20160052920-A1 | BACE1 INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2016-02-25 | — | — | US | claimed |
| WO-2016023927-A1 | 2,2,2-TRIFLUOROETHYL-THIADIAZINES | F. HOFFMANN-LA ROCHE AG (CH) | 2016-02-18 | — | — | WO | claimed |
| EP-2984086-A1 | BACE1 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2016-02-17 | — | — | EP | claimed |
| US-9067926-B2 | Fluoromethyl-5,6-dihydro-4H-[1,3]OXAZINES | HOFFMANN-LA ROCHE INC. (US) | 2015-06-30 | — | — | US | claimed |
| US-20150031690-A1 | FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZINES | F. HOFFMANN-LA ROCHE AG (CH) | 2015-01-29 | — | — | US | claimed |
| EP-2807155-A1 | FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZINES | F.HOFFMANN-LA ROCHE AG (CH) | 2014-12-03 | — | — | EP | claimed |
| WO-2014166906-A1 | BACE1 INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2014-10-16 | — | — | WO | claimed |
| WO-2013110622-A1 | FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZINES | F. HOFFMANN-LA ROCHE AG (CH) | 2013-08-01 | — | — | WO | claimed |
| US-8389513-B2 | 2-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides | HOFFMANN-LA ROCHE INC. (US) | 2013-03-05 | — | — | US | claimed |
| EP-2509965-A1 | 2-AMINO-5, 5-DIFLUORO-5, 6-DIHYDRO-4H-OXAZINES AS BACE 1 AND/OR BACE 2 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2012-10-17 | — | — | EP | claimed |
| US-20110144097-A1 | 2-AMINO-5,5-DIFLUORO-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-PHENYL]-AMIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2011-06-16 | — | — | US | claimed |
| WO-2011069934-A1 | 2-AMINO-5, 5-DIFLUORO-5, 6-DIHYDRO-4H-OXAZINES AS BACE 1 AND/OR BACE 2 INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-06-16 | — | — | WO | claimed |
| EP-3180330-B1 | 2,2,2-TRIFLUOROETHYL-THIADIAZINES | HOFFMANN LA ROCHE (CH) | 2021-03-03 | — | — | EP | disclosed |
| US-9896438-B2 | 2,2,2-trifluoroethyl-thiadiazines | HOFFMANN-LA ROCHE INC. (US) | 2018-02-20 | — | — | US | disclosed |
| US-7837982-B2 | Imaging agents | EMORY UNIVERSITY (US) | 2010-11-23 | — | — | US | disclosed |
| US-20070082879-A1 | Imaging Agents | EMORY UNIVERSITY (US) | 2007-04-12 | — | — | US | disclosed |